ShareValue.ai

ShareValue scores for 2190.HK: Valuation 37, Quality 73, Growth 59, Health 58.

2190.HK
HKEX

Zylox-Tonbridge Med Tech Co

HK$17.35(-2.36%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-4% to 10%
Valuation
37
Overvalued
Price vs Value
Quality
73
Strong
Business Strength
Growth
59
Moderate
Revenue & Earnings
Health
58
Moderate
Financial Stability
Momentum
30
Bearish
Price Trend

Company Details

About

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally. It offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. The company's peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as covers hemodialysis access, arterial, venous, peripheral embolization intervention, and other intervention products. In addition, the company provides technical consultation and services, as well as imports materials. It serves patients and physicians. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.

Score Analysis

AI Investment Thesis

Data as of:Jun 29, 2026
|
Last calculated:Jun 29, 2026